169 filings
8-K
PGEN
Precigen Inc
14 May 24
Precigen Reports First Quarter 2024 Financial Results and Business Updates
5:19pm
8-K
PGEN
Precigen Inc
19 Mar 24
Precigen Reports Full Year 2023 Financial Results and Business Updates
4:17pm
8-K
PGEN
Precigen Inc
8 Feb 24
Departure of Directors or Certain Officers
4:25pm
8-K
PGEN
Precigen Inc
8 Jan 24
Precigen Highlights Pipeline Updates to be Presented at the 42nd Annual J.P. Morgan Healthcare Conference
8:39am
8-K
PGEN
Precigen Inc
9 Nov 23
Precigen Reports Third Quarter 2023 Financial Results and Progress of Clinical Programs
5:07pm
8-K
pb3mez1nndsg7
9 Aug 23
Results of Operations and Financial Condition
8:15am
8-K
88teh5k5 82uki
9 Jun 23
Departure of Directors or Certain Officers
4:32pm
8-K
dtkfj3
10 May 23
Precigen Reports First Quarter 2023 Financial Results and Business Updates
8:00am
8-K
5rj430ifmecd q9u7ztn
4 Apr 23
Entry into a Material Definitive Agreement
9:16pm
8-K
lvczo8
13 Mar 23
Regulation FD Disclosure
6:06am
8-K
0z4ujqu
6 Mar 23
Precigen Reports Fourth Quarter and Full Year 2022 Financial Results and Business Updates
4:13pm
8-K
puek u9qw7czl3mvi4r
27 Jan 23
Entry into a Material Definitive Agreement
8:31am
8-K
nrh7clw 0c
24 Jan 23
Results of Operations and Financial Condition
4:10pm
8-K
rcwh5yn9
11 Jan 23
Precigen Provides Pipeline and Corporate Updates at the 41st Annual J.P. Morgan Healthcare Conference
7:01pm
8-K
0b4zl
9 Nov 22
Precigen Reports Third Quarter 2022 Financial Results and Progress of Clinical Programs
4:14pm
8-K
ko3edj83qd gh5
21 Sep 22
Precigen Names Rutul R. Shah Chief Operating Officer
5:07pm
8-K/A
qi940a azv84xsi
24 Aug 22
Financial Statements and Exhibits
4:28pm
8-K
aasa53d
22 Aug 22
Precigen Completes Sale of Non-Healthcare Subsidiary Trans Ova Genetics
8:47am
8-K
i0zfx2eg3
9 Aug 22
Entry into a Material Definitive Agreement
12:00am
8-K
b6l93e a9
8 Aug 22
Precigen Reports Second Quarter and First Half 2022 Financial Results
4:10pm